• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROPORT ORTHOPEDICS INC. ADVANCE PRIMARY FEMORAL SIZE 3 RIGHT POROUS; KNEE COMPONENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROPORT ORTHOPEDICS INC. ADVANCE PRIMARY FEMORAL SIZE 3 RIGHT POROUS; KNEE COMPONENT Back to Search Results
Model Number KFTCPC3R
Medical Device Problem Code Unstable (1667)
Health Effect - Clinical Code No Information (3190)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event will be updated once the investigation is complete.Trends will be evaluated.
 
Event or Problem Description
Allegedly, patient is having instability problems in his right knee.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCE PRIMARY FEMORAL SIZE 3 RIGHT POROUS
Common Device Name
KNEE COMPONENT
Manufacturer (Section D)
MICROPORT ORTHOPEDICS INC.
5677 airline rd.
arlington TN 38002
MDR Report Key9787638
Report Number3010536692-2020-00177
Device Sequence Number11316776
Product Code MBH
UDI-Device IdentifierM684KFTCPC3R1
UDI-PublicM684KFTCPC3R1
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K061223
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2002
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Model NumberKFTCPC3R
Device Catalogue NumberKFTCPC3R
Device Lot Number121A150219
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date02/12/2020
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/12/2020
Supplement Date Received by Manufacturer02/12/2020
Initial Report FDA Received Date03/04/2020
Supplement Report FDA Received Date09/18/2020
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-